What is Organon's other current assets?

Organon (OGN) reported other current assets of $1.06B in Q1 2026.

How has Organon's other current assets changed year-over-year?

Organon's other current assets increased by 5.4% year-over-year, from $1.01B to $1.06B.

What is the long-term trend for Organon's other current assets?

Over 5 years (2020 to 2025), Organon's other current assets has grown at a 2.1% compound annual growth rate (CAGR), from $930M to $1.03B.

Organon OGN Other current assets

Other current assets at other companies

PfizerPFE

——

AmgenAMGN

——

BiogenBIIB

——

ViatrisVTRS

——

Ionis PharmaceuticalsIONS

——

Merck & Co.MRK

——

Other financials

Income statement

See full

Revenue$1.5B-3.5%

Gross profit$783.0M-6.9%

Net income$146.0M+67.8%

EPS (diluted)$0.55+66.7%

Balance sheet

See full

Cash & equivalents$1.1B+104%

Total debt$8.6B-4.3%

Total equity$903.0M+66.6%

Total assets$13.0B-1.2%

Cash flow

See full

Operating cash flow$225.0M+200%

CapEx$37.0M+15.6%

Free cash flow$188.0M+337%

Valuation

See full

Market cap$3.53B-59.4%

Profitability

See full

Gross margin52.8%-4.4pp

Net margin8%-12.3pp

FCF margin11.1%-1.3pp

Returns & leverage

See full

Return on equity71.6%—

Debt / equity9.5×-7.0×

Current ratio2×+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Organon's other current assets?: Organon (OGN) reported other current assets of $1.06B in Q1 2026.
How has Organon's other current assets changed year-over-year?: Organon's other current assets increased by 5.4% year-over-year, from $1.01B to $1.06B.
What is the long-term trend for Organon's other current assets?: Over 5 years (2020 to 2025), Organon's other current assets has grown at a 2.1% compound annual growth rate (CAGR), from $930M to $1.03B.